{"id":"https://openalex.org/W2011586878","doi":"https://doi.org/10.1128/aac.02295-13","title":"Efficacy and Safety of AVP-21D9, an Anthrax Monoclonal Antibody, in Animal Models and Humans","display_name":"Efficacy and Safety of AVP-21D9, an Anthrax Monoclonal Antibody, in Animal Models and Humans","publication_year":2014,"publication_date":"2014-04-15","ids":{"openalex":"https://openalex.org/W2011586878","doi":"https://doi.org/10.1128/aac.02295-13","mag":"2011586878","pmid":"https://pubmed.ncbi.nlm.nih.gov/24733473","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4068543"},"language":"en","primary_location":{"id":"doi:10.1128/aac.02295-13","doi":"https://doi.org/10.1128/aac.02295-13","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02295-13","pdf_url":"https://aac.asm.org/content/aac/58/7/3618.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aac.asm.org/content/aac/58/7/3618.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023455415","display_name":"Nina V. Malkevich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118023","display_name":"Emergent BioSolutions (United States)","ror":"https://ror.org/027970q43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nina V. Malkevich","raw_affiliation_strings":["Emergent BioSolutions, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emergent BioSolutions, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210118023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103430277","display_name":"Robert J. Hopkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118023","display_name":"Emergent BioSolutions (United States)","ror":"https://ror.org/027970q43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Hopkins","raw_affiliation_strings":["Emergent BioSolutions, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emergent BioSolutions, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210118023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089759148","display_name":"Edward W. Bernton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118023","display_name":"Emergent BioSolutions (United States)","ror":"https://ror.org/027970q43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Bernton","raw_affiliation_strings":["Emergent BioSolutions, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emergent BioSolutions, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210118023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110396429","display_name":"Gabriel T. Meister","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325736334","display_name":"Battelle","ror":"https://ror.org/01h5tnr73","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1325736334"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel T. Meister","raw_affiliation_strings":["Battelle Biomedical Research Center (BBRC), West Jefferson, Ohio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Battelle Biomedical Research Center (BBRC), West Jefferson, Ohio, USA","institution_ids":["https://openalex.org/I1325736334"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103600326","display_name":"Eric M. Vela","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325736334","display_name":"Battelle","ror":"https://ror.org/01h5tnr73","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1325736334"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric M. Vela","raw_affiliation_strings":["Battelle Biomedical Research Center (BBRC), West Jefferson, Ohio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Battelle Biomedical Research Center (BBRC), West Jefferson, Ohio, USA","institution_ids":["https://openalex.org/I1325736334"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005485389","display_name":"George J. Atiee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092059","display_name":"Worldwide Clinical Trials (United States)","ror":"https://ror.org/00cj4je85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Atiee","raw_affiliation_strings":["Worldwide Clinical Trials, San Antonio, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Clinical Trials, San Antonio, Texas, USA","institution_ids":["https://openalex.org/I4210092059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108508077","display_name":"Virginia Redwine Johnson","orcid":"https://orcid.org/0000-0002-4489-0848","observed_orcids":["https://orcid.org/0000-0002-4489-0848"]},"institutions":[{"id":"https://openalex.org/I4210118023","display_name":"Emergent BioSolutions (United States)","ror":"https://ror.org/027970q43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Virginia Johnson","raw_affiliation_strings":["Emergent BioSolutions, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emergent BioSolutions, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210118023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051174207","display_name":"Gary S. Nabors","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118023","display_name":"Emergent BioSolutions (United States)","ror":"https://ror.org/027970q43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary S. Nabors","raw_affiliation_strings":["Emergent BioSolutions, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emergent BioSolutions, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210118023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043349782","display_name":"Ronald T. Aimes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118023","display_name":"Emergent BioSolutions (United States)","ror":"https://ror.org/027970q43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald T. Aimes","raw_affiliation_strings":["Emergent BioSolutions, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emergent BioSolutions, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210118023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039298119","display_name":"Boris I. Ionin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118023","display_name":"Emergent BioSolutions (United States)","ror":"https://ror.org/027970q43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Boris Ionin","raw_affiliation_strings":["Emergent BioSolutions, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emergent BioSolutions, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210118023"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054805608","display_name":"Mario H. Skiadopoulos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118023","display_name":"Emergent BioSolutions (United States)","ror":"https://ror.org/027970q43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mario H. Skiadopoulos","raw_affiliation_strings":["Emergent BioSolutions, Gaithersburg, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emergent BioSolutions, Gaithersburg, Maryland, USA","institution_ids":["https://openalex.org/I4210118023"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1325,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.75160184,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"58","issue":"7","first_page":"3618","last_page":"3625"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11515","display_name":"Bacillus and Francisella bacterial research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11515","display_name":"Bacillus and Francisella bacterial research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anthrax","display_name":"anthrax","score":0.6710000038146973},{"id":"https://openalex.org/keywords/bacillus-anthracis","display_name":"Bacillus anthracis","score":0.9860000014305115},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8650000095367432},{"id":"https://openalex.org/keywords/inhalational-anthrax","display_name":"inhalational anthrax","score":0.9509999752044678},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8790000081062317},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.9610000252723694},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.9369999766349792},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.656000018119812},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.6499999761581421},{"id":"https://openalex.org/keywords/cynomolgus-macaques","display_name":"cynomolgus macaques","score":0.828000009059906},{"id":"https://openalex.org/keywords/rabbits","display_name":"rabbits","score":0.5820000171661377},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C2780239966","wikidata":"https://www.wikidata.org/wiki/Q614156","display_name":"Bacillus anthracis","level":3,"score":0.9294775724411011},{"id":"https://openalex.org/C2777289321","wikidata":"https://www.wikidata.org/wiki/Q4007170","display_name":"Anthrax vaccines","level":5,"score":0.6888558864593506},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6378885507583618},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5868944525718689},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5760380625724792},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5738535523414612},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.44588860869407654},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4271414279937744},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41745516657829285},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4156706929206848},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.41010576486587524},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3778524696826935},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.27869313955307007},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.24794313311576843},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20471054315567017},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.11409205198287964},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.07418414950370789},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C167508917","wikidata":"https://www.wikidata.org/wiki/Q578537","display_name":"DNA vaccination","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000080908","descriptor_name":"Broadly Neutralizing Antibodies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000881","descriptor_name":"Anthrax","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000881","descriptor_name":"Anthrax","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000942","descriptor_name":"Antigens, Bacterial","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016470","descriptor_name":"Bacteremia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016470","descriptor_name":"Bacteremia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.02295-13","doi":"https://doi.org/10.1128/aac.02295-13","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02295-13","pdf_url":"https://aac.asm.org/content/aac/58/7/3618.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4068543","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4068543","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:24733473","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24733473","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1128/aac.02295-13","doi":"https://doi.org/10.1128/aac.02295-13","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02295-13","pdf_url":"https://aac.asm.org/content/aac/58/7/3618.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7464387428","display_name":null,"funder_award_id":"HHSN 272200800040C","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"}],"funders":[{"id":"https://openalex.org/F4320332162","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"}],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2011586878.pdf"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W85329026","https://openalex.org/W128966539","https://openalex.org/W1563690785","https://openalex.org/W1978323298","https://openalex.org/W1983489319","https://openalex.org/W1983985025","https://openalex.org/W1988669638","https://openalex.org/W1993138958","https://openalex.org/W2018506593","https://openalex.org/W2084650506","https://openalex.org/W2089728938","https://openalex.org/W2098248452","https://openalex.org/W2098440651","https://openalex.org/W2123792660","https://openalex.org/W2128581526","https://openalex.org/W2130875615","https://openalex.org/W2133344377","https://openalex.org/W2133957205","https://openalex.org/W2135069977","https://openalex.org/W2136218146","https://openalex.org/W2146050183","https://openalex.org/W2146613023","https://openalex.org/W2150832852","https://openalex.org/W2153968029","https://openalex.org/W2154586372","https://openalex.org/W2156009649","https://openalex.org/W2164782492","https://openalex.org/W2164898388","https://openalex.org/W4255260655"],"related_works":["https://openalex.org/W2123792660","https://openalex.org/W2133957205","https://openalex.org/W2146050183","https://openalex.org/W2084650506","https://openalex.org/W2346926481","https://openalex.org/W2136218146","https://openalex.org/W2098248452","https://openalex.org/W7097163522","https://openalex.org/W2313888559","https://openalex.org/W2905557379"],"abstract_inverted_index":{"Anthrax":[0],"is":[1,66],"an":[2],"acute":[3],"infectious":[4],"disease":[5,23],"caused":[6],"by":[7],"the":[8,19,48,136,142,154,162,165,185,192],"spore-forming":[9],"bacterium":[10],"Bacillus":[11],"anthracis.":[12],"Timely":[13],"administration":[14],"of":[15,21,51,78,110,144,159,180,184,191,196],"antibiotics":[16],"approved":[17],"for":[18,153],"treatment":[20,174],"anthrax":[22,44,54,63,74],"may":[24,37],"prevent":[25],"associated":[26],"morbidity":[27],"and":[28,87,93,96,116,127,161,187,209],"mortality.":[29],"However,":[30],"any":[31],"delay":[32],"in":[33,39,80,88,100,112,141,178,201],"initiating":[34],"antimicrobial":[35],"therapy":[36],"result":[38],"increased":[40],"mortality,":[41],"as":[42,59,69],"inhalational":[43],"progresses":[45],"rapidly":[46],"to":[47,124,129,146,182,189],"toxemic":[49],"phase":[50],"disease.":[52],"An":[53],"antitoxin,":[55],"AVP-21D9,":[56],"also":[57],"known":[58],"Thravixa":[60],"(fully":[61],"human":[62,102],"monoclonal":[64],"antibody),":[65],"being":[67],"developed":[68],"a":[70],"therapeutic":[71,170],"agent":[72],"against":[73],"toxemia.":[75],"The":[76,104],"efficacy":[77,171],"AVP-21D9":[79,111,160,176,197],"B.":[81],"anthracis-infected":[82],"New":[83],"Zealand":[84],"White":[85],"rabbits":[86,115,186],"cynomolgus":[89],"macaques":[90],"was":[91,140,151],"evaluated,":[92,208],"its":[94],"safety":[95],"pharmacokinetics":[97],"were":[98,198,214],"assessed":[99],"healthy":[101,134,202],"volunteers.":[103],"estimated":[105],"mean":[106,137],"elimination":[107,138],"half-life":[108,139],"values":[109],"surviving":[113],"anthrax-challenged":[114],"nonhuman":[117],"primates":[118],"(NHPs)":[119],"ranged":[120],"from":[121],"approximately":[122],"2":[123],"4":[125],"days":[126],"6":[128],"11":[130],"days,":[131],"respectively.":[132],"In":[133,169],"humans,":[135],"range":[143],"20":[145],"27":[147],"days.":[148],"Dose":[149],"proportionality":[150],"observed":[152],"maximum":[155],"serum":[156],"concentration":[157],"(Cmax)":[158],"area":[163],"under":[164,223],"concentration-time":[166],"curve":[167],"(AUC).":[168],"animal":[172],"models,":[173],"with":[175],"resulted":[177],"survival":[179],"up":[181,188],"92%":[183],"67%":[190],"macaques.":[193],"Single":[194],"infusions":[195],"well":[199],"tolerated":[200],"adult":[203],"volunteers":[204],"across":[205],"all":[206],"doses":[207],"no":[210],"serious":[211],"adverse":[212],"events":[213],"reported.":[215],"(This":[216],"study":[217],"has":[218],"been":[219],"registered":[220],"at":[221],"ClinicalTrials.gov":[222],"registration":[224],"no.":[225],"NCT01202695.).":[226]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}